$1.390
+0.320 (+23.01%)終値時点
- 高値
- 1.450
- 始値
- 1.320
- 出来高加重平均価格
- 1.30
- 出来高
- 11.88M
- 時価総額
- —
- 安値
- 1.070
- 売買代金
- 15.48M
- EV/EBITDA（TTM）
- 0.00
PomDoctor Ltd is a holding company principally engaged in the operation of online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment includes providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment includes pharmacy retail sales and wholesale. The Company mainly conducts its business in the domestic market.
AI分析 of PomDoctor Ltd (POM)
中立PomDoctor Ltd is currently not a strong buy due to significant financial challenges, despite a recent price surge. The stock closed at 1.17, down 42.36% yesterday, and has a negative forward P/E ratio, indicating ongoing losses. The recent 5-day change of +85.21% suggests volatility, but the year-to-date change of -80.06% raises concerns about long-term stability. The main risk is the company's current ratio of 0.35, indicating potential liquidity issues.
バリュエーション指標
イベントタイムライン
ニュース
8.510-19PRnewswirePomdoctor Terminates ADR Program, Lists on Nasdaq
- 8.510-12PRnewswire
Pomdoctor Advances Predictive Healthcare Transformation
- 8.510-09PRnewswire
Pomdoctor Faces Nasdaq Delisting Risk Due to Low Share Price
- 7.509-30PRnewswire
Pomdoctor Advances AI Chronic Disease Management System
7.509-30NewsfilterPomdoctor Advances AI Chronic Disease Management System
POM のよくある質問 — Alphio AI が回答
PomDoctor Ltd is a holding company principally engaged in the operation of online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment includes providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment includes pharmacy retail sales and wholesale. The Company mainly conducts its business in the domestic market. It operates in the Healthcare sector.
PomDoctor Ltd is currently not a strong buy due to significant financial challenges, despite a recent price surge. The stock closed at 1.17, down 42.36% yesterday, and has a negative forward P/E ratio, indicating ongoing losses. The recent 5-day change of +85.21% suggests volatility, but the year-to-date change of -80.06% raises concerns about long-term stability. The main risk is the company's current ratio of 0.35, indicating potential liquidity issues.
コミュニティ
もっと見る ↗投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。